I am not underwriting a software-style
rerating. I am underwriting that Serve becomes a credible multi-vertical physical-AI operator with denser delivery routes, stickier hospital workflows, and a larger mix of recurring service, software, and trust-priced revenue. If that happens, investors can value it as a real operating network rather than a pilot fleet, but the company still needs proof on utilization and concentration before it deserves a premium outcome.